Search clinical trials for: Relapsed/Refractory Multiple Myeloma
Total 13130 results
-
Peking University People's HospitalNot yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
Cartesian TherapeuticsRecruitingRefractory Multiple Myeloma | Relapsed Multiple MyelomaUnited States
-
Regeneron PharmaceuticalsNot yet recruitingRelapsed/Refractory Systemic Light Chain Amyloidosis
-
Janssen-Cilag Ltd.RecruitingRelapsed/Refractory Multiple Myeloma (RRMM)France, Denmark, Israel, Spain, Italy, Germany, Sweden
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Soochow UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
OncotherapeuticsNot yet recruitingMultiple Myeloma in Relapse | Multiple Myeloma, Refractory
-
Nanjing Leads Biolabs Co.,LtdRecruitingRelapsed/Refractory Multiple MyelomaChina
-
Massachusetts General HospitalSanofi; GlaxoSmithKlineNot yet recruitingMultiple Myeloma | Refractory Multiple Myeloma | Relapsed CancerUnited States
-
IGM Biosciences, Inc.RecruitingMultiple MyelomaUnited States
-
GI Cell, Inc.RecruitingAdvanced Solid Tumors | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Non-Hodgkin LymphomaKorea, Republic of
-
Cristiana Costa Chase, DONot yet recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Ichnos Sciences SANot yet recruitingRelapsed/Refractory Multiple MyelomaAustralia
-
Second Affiliated Hospital of Soochow UniversityThe Affiliated Hospital of Xuzhou Medical UniversityRecruitingRelapsed/Refractory Multiple MyelomaChina
-
SanofiRecruitingRelapsed/Refractory Multiple Myeloma | Amyloid Light-chain AmyloidosisItaly, Australia, Hungary, United Kingdom, Czechia, Belgium, Spain
-
University of PennsylvaniaGenentech, Inc.Recruiting
-
Nanjing IASO Biotechnology Co., Ltd.Ruijin HospitalRecruitingPlasma Cell Leukemia | Relapsed/Refractory Multiple MyelomaChina
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Hrain Biotechnology Co., Ltd.First Affiliated Hospital of Wenzhou Medical University; Shanghai Changzheng...Recruiting
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.Not yet recruitingRelapsed/Refractory Multiple MyelomaChina
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
Weijun FuNanjing Legend Biotech Co.RecruitingRelapsed/Refractory Multiple MyelomaChina
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
Chunrui LiInnovent Biologics (Suzhou) Co. Ltd.RecruitingRelapsed/Refractory Multiple MyelomaChina
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
Chunrui LiNanjing IASO Biotechnology Co., LtdRecruitingPlasma Cell Leukemia | Relapsed/Refractory Multiple MyelomaChina
-
Janssen Pharmaceutica N.V., BelgiumRecruitingRelapsed/Refractory Multiple MyelomaGermany, Italy, Belgium, Spain, Netherlands, France, United Kingdom
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
BeiGeneRecruitingRelapsed/Refractory Multiple MyelomaUnited States, China, Australia, Korea, Republic of, Canada, United Kingdom, New Zealand, Brazil
-
Juan DuRecruitingMultiple MyelomaChina
-
Li ZhengNot yet recruiting
-
Chunyan Sun, MDRecruiting
-
GlaxoSmithKlineRecruitingMultiple MyelomaChina, Korea, Republic of, Australia, Italy, Spain, United States, Brazil, Czechia, France, Germany, Greece, Israel, Japan, New Zealand, Poland, Russian Federation, Turkey, United Kingdom
-
GlaxoSmithKlineRecruitingMultiple MyelomaUnited States, Australia, France, Japan, Netherlands, Poland, Spain, Sweden, Greece, Canada, Korea, Republic of, Germany, Brazil, Israel, Mexico, Norway, Russian Federation
-
Hrain Biotechnology Co., Ltd.First Affiliated Hospital of Wenzhou Medical University; Shanghai Changzheng... and other collaboratorsRecruiting
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.RecruitingRelapsed/Refractory Multiple MyelomaUnited States, France
-
OncotherapeuticsIncyte CorporationRecruitingMultiple MyelomaUnited States
-
SanofiActive, not recruitingRelapsed/Refractory Multiple MyelomaAustralia, Czechia, Brazil, Japan, Greece, Portugal
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
Karyopharm Therapeutics IncBristol-Myers SquibbActive, not recruitingMultiple MyelomaUnited States, Canada
-
Caribou Biosciences, Inc.Enrolling by invitationLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non-Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Hematologic Malignancy | Relapsed/Refractory Multiple Myeloma | Relapsed/Refractory Acute Myeloid Leukemia | Relapsed Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin's LymphomaUnited States
-
University of California, San DiegoTakeda; Celgene; Janssen, LPActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Hellenic Society of HematologyJanssen PharmaceuticalsCompletedRelapsed/Refractory Multiple MyelomaGreece
-
University of Maryland, BaltimoreActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Zhujiang HospitalThe Third Affiliated Hospital of Southern Medical University; Sun Yat-Sen Memorial... and other collaboratorsTerminatedRelapsed/Refractory Multiple Myeloma(MM)China
-
GlaxoSmithKlineTerminatedRelapsed/Refractory Multiple MyelomaAustralia, Sweden, Canada
-
GlaxoSmithKlineActive, not recruitingMultiple MyelomaUnited States, Australia, Spain, Bulgaria, Poland, Belgium, France, Germany, Italy, Hungary, United Kingdom, Greece, Russian Federation, Brazil, China, Korea, Republic of, Japan, Canada, Netherlands
-
The First Affiliated Hospital of Soochow UniversityWithdrawnRelapsed/Refractory Multiple MyelomaChina
-
GlaxoSmithKlineTerminatedMultiple MyelomaUnited States
-
TakedaCompletedRelapsed/Refractory Multiple MyelomaJapan
-
Noah MerinTeva Branded Pharmaceutical Products R&D, Inc.; Miltenyi Biomedicine GmbHActive, not recruitingLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Chronic Lymphocytic Leukemia | CLLUnited States